Attruby™ (acoramidis) Is Now Approved – Learn More
ATTRuby™ (acoramidis) is now approved. Access the medication guide, prescribing information, and patient support services offered through ForgingBridges
Related Articles
Trump picks Johns Hopkins’ Martin Makary as FDA commissioner
The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs.
Cost-effectiveness of Implementing a Genotype-Guided De-Escalation Strategy in Patients with Acute Coronary Syndrome
AbstractAims. A genotype-guided P2Y12-inhibitor de-escalation strategy, switching acute coronary syndrome (ACS) patients without a CYP2C19 loss-of-function
Issues | European Journal of Preventive Cardiology | Oxford Academic
A peer-reviewed, international journal embracing all scientific, clinical and public health disciplines addressing the causes and prevention of cardiovascular disease, as well as cardiovascular rehabilitation,…
Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR Substudy
AbstractBackgroundObesity is a known risk factor for heart failure with preserved ejection fraction (HFpEF) and is considered a distinct phenotype with more concentric remodeling. Epicardial…
BridgeBio wins FDA approval for heart disease drug
The FDA approved a new medicine from BridgeBio for patients with ATTR-CM, a progressive heart disease
Trump picks Johns Hopkins surgeon Makary to run FDA
Makary is a close ally of Robert F. Kennedy Jr. and a proponent of his “Make America Healthy Again” movement to fight chronic diseases.
Two‐Stage Recruitment Design to Reduce Magnetic Resonance Imaging Screening Cost for a Theoretical Clinical Trial of White Matter Hyperintensity Progression | Journal of the American Heart Association
BackgroundWhite matter hyperintensities (WMH) and their progression are associated with risk of dementia and stroke, so are an important target for clinical trials. The cost…
Associations of Neighborhood Food and Physical Activity Environments in Young Adulthood With Cardiovascular Health in Midlife: The CARDIA Study | Journal of the American Heart Association
BackgroundAdults who maintain ideal cardiovascular health (CVH) profiles up to midlife have lower risk of several chronic diseases and better quality of life. Some evidence…
Trump picks Johns Hopkins surgeon Makary to run FDA
Makary is a close ally of Robert F. Kennedy Jr. and a proponent of his “Make America Healthy Again” movement to fight chronic diseases.
BridgeBio wins FDA approval for heart disease drug
The FDA approved a new medicine from BridgeBio for patients with ATTR-CM, a progressive heart disease